Buy Sutekast 50mg in UAE | Ernest Oncology – Oncology Meds Supplier

Sutekast 50mg Capsule: High-Potency Sunitinib for Advanced Cancer Care

Are you seeking a trusted Sutekast 50mg Capsule exporter from India? Ernest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading international bulk supplier and distributor. We provide high-quality oncology solutions to the USA, UK (London), UAE (Abu Dhabi), Australia, and South Africa, ensuring streamlined logistics and professional B2B service.

Product Detail: What is Sutekast 50mg?

Sutekast 50mg contains Sunitinib Malate, a powerful multi-targeted receptor tyrosine kinase (RTK) inhibitor. The 50 mg strength is the standard therapeutic dose used to manage aggressive tumor growth by disrupting the blood supply and cellular signaling of malignant cells. Manufactured under strict quality controls, Sutekast is a cost-effective and clinically equivalent alternative to global brands.

Therapeutic Indications:

Sutekast 50 mg is widely recognized for its efficacy in treating:

• Advanced Renal Cell Carcinoma (RCC): The primary treatment for advanced or metastatic kidney cancer.

• Gastrointestinal Stromal Tumor (GIST): Used when previous treatments like imatinib have failed or cannot be tolerated.

• Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors located in the pancreas.

• Adjuvant Treatment of RCC: For patients at high risk of recurrent kidney cancer following surgery.

Pharmacology and Mechanism of Action:

Sutekast works by blocking several enzymes called Tyrosine Kinases. These enzymes are found in receptors on the surface of both cancer cells and normal cells.

1. Anti-Angiogenesis: It blocks VEGFR (Vascular Endothelial Growth Factor Receptors), preventing the tumor from developing the new blood vessels it needs to "feed" and grow.

2. Anti-Proliferation: It targets PDGFR (Platelet-Derived Growth Factor Receptors) and KIT, which are vital for the survival and division of cancer cells.

By attacking the cancer from multiple angles, Sutekast 50 mg helps shrink tumors and delay disease progression.

Dosage and Administration Schedule:

• The 4/2 Cycle: For RCC and GIST, the standard protocol involves taking 50 mg once daily for 4 weeks ("on" period), followed by 2 weeks of rest ("off" period).

• Continuous Dosing: For pNET, a lower daily dose (typically 37.5 mg) is often taken continuously.

• Administration: Capsules must be swallowed whole with water. They can be taken with or without food. Avoid grapefruit juice, as it may increase the concentration of the drug in the bloodstream.

Important Safety Information:

Patients using Sutekast 50 mg should be monitored for:

• Hypertension: Blood pressure should be checked regularly.

• Hepatotoxicity: Liver function tests are required during treatment.

• Thyroid Dysfunction: Both hypothyroidism and hyperthyroidism can occur.

• Skin Reactions: "Hand-foot syndrome" (redness and peeling of skin on extremities) or skin/hair yellowing.

Why Partner with Ernest Oncology for Sutekast 50 mg?

• Strategic Global Logistics: Direct shipping to the USA, UK, UAE, Australia, and South Africa.

• Authentic Indian Exports: We source from reputable manufacturers, ensuring product integrity and GMP compliance.

• Competitive B2B Pricing: Specialized pricing models for oncology clinics, hospitals, and pharmacies.

• Expert Documentation: We handle all international pharmaceutical export regulations and customs paperwork.